カテゴリ： MarketLine, 企業調査, 香港

DBS Bank (Hong Kong) Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4011
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：40
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：香港
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

DBS Bank (Hong Kong) Limited – Strategy, SWOT and Corporate Finance Report
Summary

DBS Bank (Hong Kong) Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DBS Bank (Hong Kong) Limited (DBSHKL), a subsidiary of DBS Group Holdings Ltd, offers personal banking and business banking products and services. Personal banking comprises accounts, credit cards, loans, life and non-life insurance, retirement planning, online banking, and securities and trading services. Business banking consists of accounts, financing, insurance, cash management, trade services, treasury services, remittance services, working capital and debt capital market advisory, and market research, insights, and analysis. DBSHKL caters to retail, corporate, and SME clients through a network of bank branches, ATMs, and online portals. DBSHKL is headquartered in Hong Kong.

Scope

- Detailed information on DBS Bank (Hong Kong) Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DBS Bank (Hong Kong) Limited in the form of a SWOT analysis
- An in-depth view of the business model of DBS Bank (Hong Kong) Limited including a breakdown and examination of key business segments
- Intelligence on DBS Bank (Hong Kong) Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DBS Bank (Hong Kong) Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DBS Bank (Hong Kong) Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DBS Bank (Hong Kong) Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DBS Bank (Hong Kong) Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
DBS Bank (Hong Kong) Limited: Company Overview 9
DBS Bank (Hong Kong) Limited: Overview and Key Facts 9
DBS Bank (Hong Kong) Limited: Overview 9
DBS Bank (Hong Kong) Limited: Key Facts 9
DBS Bank (Hong Kong) Limited: Key Employees 10
DBS Bank (Hong Kong) Limited: Key Employee Biographies 11
DBS Bank (Hong Kong) Limited: Major Products and Services 12
DBS Bank (Hong Kong) Limited: Company History 16
DBS Bank (Hong Kong) Limited: Management Statement 20
DBS Bank (Hong Kong) Limited: Locations and Subsidiaries 23
DBS Bank (Hong Kong) Limited: Key Competitors 24
DBS Bank (Hong Kong) Limited: Company Analysis 25
DBS Bank (Hong Kong) Limited: Business Description 25
DBS Bank (Hong Kong) Limited: SWOT Analysis 26
DBS Bank (Hong Kong) Limited: SWOT Overview 26
DBS Bank (Hong Kong) Limited: Strengths 26
DBS Bank (Hong Kong) Limited: Weaknesses 26
DBS Bank (Hong Kong) Limited: Opportunities 27
DBS Bank (Hong Kong) Limited: Threats 28
DBS Bank (Hong Kong) Limited: Corporate Financial Deals Activity 29
DBS Bank (Hong Kong) Limited: Financial Deals Overview 29
DBS Bank (Hong Kong) Limited: Targets and Partners 30
DBS Bank (Hong Kong) Limited: Top Deals 2014 – 2018YTD* 31
DBS Bank (Hong Kong) Limited: Mergers and Acquisitions 32
DBS Bank (Hong Kong) Limited: Recent Developments 33
DBS Bank (Hong Kong) Limited: News and Events Summary 33
DBS Bank (Hong Kong) Limited: Corporate Governance 35
DBS Bank (Hong Kong) Limited: Financial Deals 35
DBS Bank (Hong Kong) Limited: IT Spending Announcements 36
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: DBS Bank (Hong Kong) Limited: Key Facts
Table 2: DBS Bank (Hong Kong) Limited: Key Employees
Table 3: DBS Bank (Hong Kong) Limited: Locations and Subsidiaries
Table 4: DBS Bank (Hong Kong) Limited: Key Competitors
Table 5: DBS Bank (Hong Kong) Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: DBS Bank (Hong Kong) Limited: M&A Average Deal Size - Value (US$m)
Table 7: DBS Bank (Hong Kong) Limited: Targets and Partners
Table 8: DBS Bank (Hong Kong) Limited: Top Deals 2014 - 2018YTD*
Table 9: DBS Bank (Hong Kong) Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: DBS Bank (Hong Kong) Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 11: DBS Bank (Hong Kong) Limited: News and Events Summary
Table 12: DBS Bank (Hong Kong) Limited: Corporate Governance
Table 13: DBS Bank (Hong Kong) Limited: Financial Deals
Table 14: DBS Bank (Hong Kong) Limited: IT Spending Announcements

List of Figures
Figure 1: DBS Bank (Hong Kong) Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: DBS Bank (Hong Kong) Limited: M&A Average Deal Size - Value (US$m)
Figure 3: DBS Bank (Hong Kong) Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: DBS Bank (Hong Kong) Limited: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[DBS Bank (Hong Kong) Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Frontage Laboratories Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC …
  • VeriSign Inc (VRSN)：企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Orion Diagnostica Oy：医療機器：M&Aディール及び事業提携情報
    Summary Orion Diagnostica Oy (Orion Diagnostica), a subsidiary of Orion Oyj, is a medical equipment company that develops, manufactures clinical diagnostic and hygiene monitoring tests. Its product portfolio provides diagnosis and treatment management kits, point of care systems, ready to use kits, …
  • ViroGates AS (VIRO)：医療機器：M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • GFH Financial Group BSC (GFH)：企業の財務・戦略的SWOT分析
    GFH Financial Group BSC (GFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Genextra Spa：製薬・医療：M&Aディール及び事業提携情報
    Summary Genextra SpA (Genextra) is a therapies developing company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, INT- 777 for metabolic syndrome, mono therapy and diabetes, novel HDAC and HSP90 inhibitors for the treatment of canc …
  • Cambrex Corp (CBM)：企業の財務・戦略的SWOT分析
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • Sienna Biopharmaceuticals Inc (SNNA)：医療機器：M&Aディール及び事業提携情報
    Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a clinical-stage biopharmaceutical company that develops and commercializes topical products in medical dermatology and aesthetics. Through its topical photoparticle therapy platform, the company advanced its product SNA-001, into …
  • Varta Microbattery GmbH：企業の戦略的SWOT分析
    Varta Microbattery GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Tung Lok Restaurants (2000) Ltd.：企業の戦略・SWOT・財務情報
    Tung Lok Restaurants (2000) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tung Lok Restaurants (2000) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Cooper Companies Inc (COO)：企業の財務・戦略的SWOT分析
    The Cooper Companies Inc (COO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Pharco Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …
  • WideMed Technologies LTD：医療機器：M&Aディール及び事業提携情報
    Summary WideMed Technologies LTD (WideMed) is a medical device company that develops and manufactures information systems for monitoring, diagnosis and analysis of sleep disorders. The company’s products include Morpheus Modules, Morpheus Hx and Morpheus Ox. Its Morpheus modules are automatic scorin …
  • NicOx SA (COX)-医療機器分野：企業M&A・提携分析
    Summary NicOx SA (NicOx) is an pharmaceutical company that develops ophthalmic portfolio of therapies and diagnostic tools. The company offers ophthalmic products which include AdenoPlus, AzaSite, BromSite, Xailin, Vesneo, next generation NO-donors and Syk and JAK inhibitors, and others. It offers p …
  • HMicro Inc-医療機器分野：企業M&A・提携分析
    Summary HMicro Inc (HMicro) is a medical device company that offers wireless sensor solutions. The company offers REACH wireless module, a wireless silicon platform that offers fully disposable and wearable wireless sensor patches for a range of professional clinical procedures in hospitals, clinics …
  • Valeant Pharmaceuticals International Inc (VRX)-医療機器分野：企業M&A・提携分析
    Summary Valeant Pharmaceuticals International Inc (Valeant) is a pharmaceutical and medical device company that carries out development, manufacture and marketing of several branded, over-the-counter (OTC) and generic drugs. The company also offers medical devices such as medical contact lenses, int …
  • Inova Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include quanta flash used for semi-quantitative determination of aut …
  • GE Global Research-医療機器分野：企業M&A・提携分析
    Summary GE Global Research (GE Global), a subsidiary of General Electric Company is a research and development company that develops technologies for various industry sectors. The company offers diverse technologies which are used in electronics, chemistry, biosciences, computing, metallurgy, fluid …
  • ALSTOM SA：企業の戦略・SWOT・財務情報
    ALSTOM SA - Strategy, SWOT and Corporate Finance Report Summary ALSTOM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • G&W Electric Company：企業の戦略的SWOT分析
    G&W Electric Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆